REGN logo

REGN Gross Margin

Annual Gross Margin

86.13%
-0.03%-0.03%

December 31, 2024

Summary

Performance

1-Year Change

-0.03%

3-Year Change

+1.53%

5-Year Change

-2.49%

15-Year Change

-7.63%

REGN Gross Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

86.61%
REGN annual gross profit margin is higher than 86.61% of companies in Healthcare sector

High & Low

All-time High

99.61%
REGN annual gross profit margin is currently -13.53% below its historical high of 99.61%

3-Year Low

84.83%
REGN annual gross profit margin is currently +1.53% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
REGN previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
REGN next annual earnings announcement has not yet been scheduled

OtherREGNprofitabilitymetrics:

Annual Revenue

$14.20 B
REGN annual revenue is $14.20 billion

Annual Gross Profit

$12.23 B
REGN annual gross profit is $12.23 billion

Annual Operating Margin

28.81%
REGN annual operating profit margin is 28.81%

Annual Net Margin

31.07%
REGN annual net profit margin is 31.07%

Quarterly Gross Margin

85.08%
-1.72%-1.98%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+0.15%

3-Year Change

+0.15%

5-Year Change

+0.15%

REGN Quarterly Gross Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.19%
REGN quarterly gross profit margin is higher than 84.19% of companies in Healthcare sector

High & Low

All-time High

99.66%
REGN quarterly gross profit margin is currently -14.63% below its historical high of 99.66%

3-Year Low

80.16%
REGN quarterly gross profit margin is currently +6.14% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
REGN previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
REGN next earnings announcement is scheduled for May 2, 2025

OtherREGNprofitabilitymetrics:

Quarterly Revenue

$3.79 B
REGN quarterly revenue is $3.79 billion

Quarterly Gross Profit

$3.22 B
REGN quarterly gross profit is $3.22 billion

Quarterly Operating Margin

26.50%
REGN quarterly operating profit margin is 26.50%

Quarterly Net Margin

24.22%
REGN quarterly net profit margin is 24.22%

Gross Margin Formula

Gross Margin =  Gross Profit
Revenue ✕ 100%

Annual Gross Margin

86.13%
REGN annual gross profit margin is 86.13%

Annual Gross Profit

$12.23 B
REGN annual gross profit is $12.23 billion

Annual Revenue

$14.20 B
REGN annual revenue is $14.20 billion

REGN Gross Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.0%+0.1%
3 y3 years+1.5%+0.1%
5 y5 years-2.5%+0.1%

REGN Gross Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-1.2%+1.5%-5.0%+6.1%
5 y5-year-2.5%+1.5%-5.0%+6.1%
alltimeall time-13.5%+214.3%-14.6%+143.8%

Regeneron Pharmaceuticals Gross Margin History

DateAnnualQuarterly
Dec 2024
86.13%(-0.0%)
85.08%(-2.0%)
Sep 2024
-
86.80%(+0.4%)
Jun 2024
-
86.46%(+0.3%)
Mar 2024
-
86.21%(+1.5%)
Dec 2023
86.16%(-1.2%)
84.95%(-2.4%)
Sep 2023
-
87.02%(-0.2%)
Jun 2023
-
87.18%(+1.9%)
Mar 2023
-
85.53%(+1.6%)
Dec 2022
87.18%(+2.8%)
84.17%(-5.6%)
Sep 2022
-
89.18%(-0.5%)
Jun 2022
-
89.60%(+3.8%)
Mar 2022
-
86.34%(+7.7%)
Dec 2021
84.83%(-2.3%)
80.16%(-7.7%)
Sep 2021
-
86.87%(+0.4%)
Jun 2021
-
86.50%(-1.5%)
Mar 2021
-
87.82%(+2.8%)
Dec 2020
86.82%(-1.7%)
85.43%(-3.0%)
Sep 2020
-
88.06%(+2.5%)
Jun 2020
-
85.89%(-2.5%)
Mar 2020
-
88.11%(+0.0%)
Dec 2019
88.33%(-3.9%)
88.10%(+1.2%)
Sep 2019
-
87.07%(-4.1%)
Jun 2019
-
90.76%(+3.8%)
Mar 2019
-
87.46%(+21.0%)
Dec 2018
91.89%(-1.4%)
72.28%(-22.6%)
Sep 2018
-
93.36%(-1.0%)
Jun 2018
-
94.30%(+2.1%)
Mar 2018
-
92.40%(-1.0%)
Dec 2017
93.24%(-0.6%)
93.32%(+0.3%)
Sep 2017
-
93.05%(+0.1%)
Jun 2017
-
93.00%(-0.7%)
Mar 2017
-
93.62%(-0.3%)
Dec 2016
93.83%(+3.8%)
93.91%(-2.6%)
Sep 2016
-
96.38%(+2.2%)
Jun 2016
-
94.31%(+4.0%)
Mar 2016
-
90.69%(+0.9%)
Dec 2015
90.43%(-2.5%)
89.91%(-0.6%)
Sep 2015
-
90.41%(-0.8%)
Jun 2015
-
91.10%(+0.8%)
Mar 2015
-
90.35%(-2.4%)
Dec 2014
92.73%(+0.1%)
92.59%(+0.3%)
Sep 2014
-
92.34%(-0.7%)
Jun 2014
-
93.03%(-0.0%)
Mar 2014
-
93.04%(+1.0%)
Dec 2013
92.62%(-1.3%)
92.12%(-1.5%)
Sep 2013
-
93.54%(+2.4%)
Jun 2013
-
91.34%(-2.2%)
Mar 2013
-
93.39%(+0.7%)
Dec 2012
93.87%(-5.2%)
92.72%(-2.7%)
Sep 2012
-
95.29%(+2.7%)
Jun 2012
-
92.82%(-2.0%)
Mar 2012
-
94.69%(-3.0%)
Dec 2011
99.05%(-0.5%)
97.57%(-2.0%)
Sep 2011
-
99.56%(-0.1%)
Jun 2011
-
99.63%(-0.0%)
Mar 2011
-
99.66%(+0.1%)
DateAnnualQuarterly
Dec 2010
99.54%(-0.0%)
99.55%(-0.1%)
Sep 2010
-
99.65%(0.0%)
Jun 2010
-
99.65%(+0.3%)
Mar 2010
-
99.31%(-0.3%)
Dec 2009
99.56%(-0.1%)
99.60%(0.0%)
Sep 2009
-
99.60%(+0.1%)
Jun 2009
-
99.52%(+0.0%)
Mar 2009
-
99.48%(+0.6%)
Dec 2008
99.61%(+14.3%)
98.87%(-0.7%)
Sep 2008
-
99.55%(+3.9%)
Dec 2006
87.16%(+1.9%)
95.84%(+19.1%)
Sep 2006
-
80.45%(-5.8%)
Jun 2006
-
85.41%(-4.9%)
Mar 2006
-
89.83%(+2.4%)
Dec 2005
85.56%(-6.2%)
87.69%(+9.7%)
Sep 2005
-
79.96%(-10.9%)
Jun 2005
-
89.77%(+6.1%)
Mar 2005
-
84.63%(-8.6%)
Dec 2004
91.26%(+3.2%)
92.62%(+22.9%)
Sep 2004
-
75.39%(-23.2%)
Jun 2004
-
98.14%(+1.8%)
Mar 2004
-
96.41%(+0.7%)
Dec 2003
88.39%(+25.3%)
95.74%(+32.7%)
Sep 2003
-
72.15%(-25.7%)
Jun 2003
-
97.09%(+3.9%)
Mar 2003
-
93.43%(+44.0%)
Dec 2002
70.52%(+0.2%)
64.86%(-13.6%)
Sep 2002
-
75.07%(+12.8%)
Jun 2002
-
66.58%(-10.7%)
Mar 2002
-
74.52%(+1.3%)
Dec 2001
70.38%(-4.6%)
73.60%(-4.1%)
Sep 2001
-
76.75%(+13.9%)
Jun 2001
-
67.38%(+3.1%)
Mar 2001
-
65.34%(+20.2%)
Dec 2000
73.74%(-17.7%)
54.34%(-34.7%)
Sep 2000
-
83.25%(-8.8%)
Jun 2000
-
91.31%(+28.7%)
Mar 2000
-
70.94%(-28.5%)
Dec 1999
89.57%(+3.0%)
99.16%(+8.8%)
Sep 1999
-
91.15%(+14.4%)
Jun 1999
-
79.66%(+4.9%)
Mar 1999
-
75.93%(-3.8%)
Dec 1998
86.95%(-3.7%)
78.95%(-10.2%)
Sep 1998
-
87.96%(-3.5%)
Jun 1998
-
91.11%(+5.8%)
Mar 1998
-
86.15%(+4.2%)
Dec 1997
90.33%(-5.4%)
82.69%(-9.1%)
Sep 1997
-
91.01%(-1.5%)
Jun 1997
-
92.42%(+0.5%)
Mar 1997
-
91.94%(-147.3%)
Dec 1996
95.44%(-226.7%)
-
Sep 1993
-
-194.44%(+29.6%)
Dec 1991
-75.34%(+189.8%)
-150.00%(+469.9%)
Sep 1991
-
-26.32%(-62.7%)
Jun 1991
-
-70.59%
Dec 1990
-26.00%
-

FAQ

  • What is Regeneron Pharmaceuticals annual gross profit margin?
  • What is the all time high annual gross margin for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual gross margin year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly gross profit margin?
  • What is the all time high quarterly gross margin for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly gross margin year-on-year change?

What is Regeneron Pharmaceuticals annual gross profit margin?

The current annual gross margin of REGN is 86.13%

What is the all time high annual gross margin for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual gross profit margin is 99.61%

What is Regeneron Pharmaceuticals annual gross margin year-on-year change?

Over the past year, REGN annual gross profit margin has changed by -0.03% (-0.03%)

What is Regeneron Pharmaceuticals quarterly gross profit margin?

The current quarterly gross margin of REGN is 85.08%

What is the all time high quarterly gross margin for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly gross profit margin is 99.66%

What is Regeneron Pharmaceuticals quarterly gross margin year-on-year change?

Over the past year, REGN quarterly gross profit margin has changed by +0.13% (+0.15%)